Work

Long Term Observations and Mortality Rates in ALS Patients Treated with Autologous Mesenchymal Cell Transplantations

Year: 2025

Type: article

Abstract: Survival in ALS is highly variable, ranging from a few months to many years. Population-based prospective registries showed that up to a third of the patients die within one year from diagnosis [1-3]. In this short communication we present our long-term observations (~15 years) in terms of severe adverse events and survival rates, in patients treated with autologous mesenchymal stem cells, who participated in 3 previous open-label studies, in our center at Hadassah Medical Organization in Jerusalem, Israel.

Source: Open access Journal of Neurology & Neurosurgery

DOI: 10.19080/oajnn.2025.19.556017

Author: Petrou Panayiota

Institution: Hadassah Medical Center

Language: English

Topic: Amyotrophic Lateral Sclerosis Research

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4410417842